ENTITY
Sanofi

Sanofi (SAN FP)

78
Analysis
Health CareFrance
Sanofi operates as a pharmaceutical company. The Company manufactures prescription pharmaceuticals and vaccines. Sanofi also develops cardiovascular, thrombosis, metabolic disorder, central nervous system, and oncology medicines and drugs. Sanofi serves customers worldwide.
more
Refresh
25 Nov 2022 01:30

2023 High Conviction: Revolution Medicines – Cracking The KRAS In Cancer

Oncology-focused unicorn Revolution Medicines is our high-risk/high-reward conviction idea for 2023 as we see room for further gains among select...

Logo
499 Views
Share
08 Nov 2022 19:14

Takeda: A Deep Dive into Takeda’s Dengue Vaccine

As Takeda prepares to launch its dengue vaccine QDENGA, we take a look at the company's journey into dengue research, Sanofi's fiasco and the...

Share
29 Jul 2022 06:37

France: Europe’s High Conviction Holding

Global equity funds are at record overweights in French equities. Average weights are towards the top end of the 8-year range at 4.16%, pushing net...

Logo
253 Views
Share
12 Jul 2022 23:15

Data Mining Technical Publications to Rank the Innovators in RNA Therapeutics

Specialists lead the RNA intellectual property ecosystem but may still need big pharma  to bring new treatments to market making the space ripe for...

Logo
350 Views
Share
bearishCopper
28 Jun 2022 23:38

Signs of Disinflation?; Commodities Deteriorating; Another Bear Market Bounce; Pharma/Biotech Buys

A bear market bounce is underway after the SPX, QQQ, and IWM found support at their respective downtrend channels. Until these indexes can break...

Logo
331 Views
Share
x